News
Apotex has launched the first generic version of GlaxoSmithKline blockbuster antidepressant Paxil (paroxetine) in the US, several months earlier than...
A new rival to blockbuster Cox-II inhibitor drugs from Pfizer and Merck Sharp & Dohme has been approved in the UK.
A special World Health Organisation team has praised the groundbreaking work of NICE but has called for its dealing with industry to be more...
A new private European pharma company has been launched that will exploit products made available through the spate of industry mergers, acquisitions...
AstraZeneca has become the second major pharma company to limit sales of drugs to Canada in a bid to curb parallel imports across the border into the...
Pharmaceutical industry 'disease awareness campaigns' aimed at UK consumers are to be governed by new guidelines to formalise the practice and clear...
GlaxoSmithKline has landed a marketing coup by agreeing a sponsorship deal with the BMW WilliamsF1 team for its smoking cessation product NiQuitin CQ.
New guidance has been issued to help nurses and GPs take on extra roles that will expand primary care services.